Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer

Clinical trial NCT03503799 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT03503799
Sponsor: North Eastern German Society of Gynaecological Oncology
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Primary Invasive Breast Cancer Estrogen Receptor Positive Tumor Human Epidermal Growth Factor Receptor 2 Negative Tumor

Start date: 2018-07-17
Primary completion: 2032-10-01
Enrollment: 1191

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.